
Sign up to save your podcasts
Or
Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.
4.7
16081,608 ratings
Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.
4,139 Listeners
480 Listeners
3,207 Listeners
828 Listeners
2,170 Listeners
1,383 Listeners
3,371 Listeners
807 Listeners
1,500 Listeners
924 Listeners
2,296 Listeners
570 Listeners
378 Listeners
849 Listeners
1,529 Listeners
412 Listeners
238 Listeners